| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |